Ellex to Launch Innovative New Ultrasound Technology at ASCRS

Ellex Medical Lasers announced the market launch of the company’s Eye Prime diagnostic ultrasound technology that is essential for evaluating pathology of the eye. FDA clearance was received on April 12, 2019.

This proprietary diagnostic advance features a multifocal array of 6 focal points to provide the doctor with crisp focus to improve image definition and clarity. The increased depth of field as well as real time dynamic imaging permits materially enhanced viewing of the fine and intricate structures inside the eye. These structures cannot be seen with currently available competitive offerings.

“Ellex’s Eye Prime technology greatly enhances my ability to follow intraocular tumours and more precisely analyse their characteristics,” Timothy Fuller, MD, Ocular Oncologist and Medical Retina Specialist of Texas Retina Associates, said in a company news release. “As a medical retina specialist, the improvements in resolution of the Eye Prime help me better diagnose and treat other retinal conditions including tears and vitreous detachments.”

Inder Paul Singh, MD, from the Eye Centres of Racine and Kenosha, Wisconsin highlighted a scientific case series illustrating real-time visualization of vitreous floaters with the Eye Prime during laser treatment. The case series offered evidence as to the safety profile of this novel treatment approach. It also highlighted the superior clinical imaging ability of Eye Prime Technology. 

“I am pleased we have received FDA clearance for Eye Prime and launched this sophisticated diagnostic ultrasound innovation, in the key US market,” Ged Wallace, Chief Executive Officer of Ellex, said in the news release. “Initial clinician feedback, touched on above, has been highly positive, and has reinforced our goal of delivering technologies that benefit our Medical clients and their deserving patients.”